The unfortunate consequences of the rarity of "single psychiatric drugs".
Chronic patients do not have the option of changing medicine.
Mohammad Reza Shlabafan, Director General of the Bureau of Mental Health, Society and Addictions at the Ministry of Health, Treatment and Medical Education in an interview with Mizen: Although there is no nationwide shortage of an entire medication category, the challenge of providing "single medications" to psychiatric patients who cannot change medications is a crisis.
The Food and Drug Administration needs to support the supply chain of drugs for this vulnerable group with greater speed and accuracy.
The problems of the pharmaceutical industry are not hidden from anyone, but the issues related to psychiatric drugs require serious and urgent intervention and attention.
Many psychiatric patients cannot easily exchange their medications with similar samples due to high clinical sensitivity; Therefore, the supply of individual drugs is of vital importance, even if an entire class of drugs is not uncommon.
More details.
Rank in social networks.